Evercore ISI Group Maintains Outperform on Caribou Biosciences, Raises Price Target to $13
Evercore ISI Group analyst Jonathan Miller maintains Caribou Biosciences (NASDAQ:CRBU) with a Outperform and raises the price target from $11 to $13.
Login to comment